Kolexia
Roussel-Robert Valerie
Hématologie
Hôpital Cochin
Paris, France
44 Activités
9 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Hémorragie Hémarthrose Hémophilie B Hypertension artérielle Déficit en facteur XI Neurinome Maladies de von Willebrand Thrombasthénie

Industries

Sobi
3 collaboration(s)
Dernière en 2022
Takeda Pharmaceutical
2 collaboration(s)
Dernière en 2021
Inter-View Partners France
2 collaboration(s)
Dernière en 2020
LFB
2 collaboration(s)
Dernière en 2023

Dernières activités

Hémophilie
HAS Publications   20 juin 2023
Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders.
European journal of haematology   20 février 2023
Assessment of the clinical perception, quality of life and satisfaction of patients with severe congenital haemophilia A without inhibitor after 1 year of emicizumab therapy.
Haemophilia : the official journal of the World Federation of Hemophilia   07 février 2023
Assessment of the budgetary impact of an emicizumab therapy introduction for patients with severe haemophilia A without inhibitor.
Annales pharmaceutiques francaises   12 novembre 2022
121.1 Pregnancy in women with factor XI deficiency (<60 UI/dl) and use of neuraxial analgesia: Real life data in a French cohort of 314 pregnancies
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
A case of Epstein-Barr virus-associated smooth muscle tumor of the posterior interosseous nerve mimicking schwannoma.
Neuropathology : official journal of the Japanese Society of Neuropathology   13 janvier 2022
Maladie de Willebrand
HAS Publications   09 mars 2021
The Hemarthrosis-Simulating Knee Model: A Useful Tool for Individualized Education in Patients with Hemophilia (GEFACET Study).
Journal of blood medicine   09 mars 2021
Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life study.
European journal of pharmacology   27 novembre 2020
Monitoring and Pharmacodynamic Effect of Eftrenonacog-Alfa (Alprolix®) in Severe Hemophilia B Patients: A Real-Life Study
Abstracts of the ISTH 2020 Virtual Congress of the International Society on Thrombosis and Haemostasis, July 12–14, 2020   11 août 2020